pharma

Alexion's Soliris (eculizumab) product sales up 4% to $756 mil during the September quarter. Hope the FDA approval for Soliris for Myasthenia Gravis patients will boost the sales in the coming months. My granny has this disorder. I don't know when this drug will be available in the market?

https://alphastreet.com/bite/d578727 Amgen, that is in the process of refreshing its product portfolio, reported higher-than-expected 3Q profit, but sales declined in some of its biggest established products.

https://alphastreet.com/bite/d578727 Amgen, that is in the process of refreshing their product portfolios, reported higher-than-expected 3Q profit, but sales declined in some of its biggest established products.

Allergan faces another trouble. Imprimis Pharma to produce alternative medicine for Restasis. http://alph.st/p97f8975

Johnson&Johnson is discontinuing clinical trials on two potentially blockbuster drugs. Bad timing I would say. I wonder how the company plans to maintain its growth in Pharma sales without these drugs. Source Article

Hey Folks, I'm a journalist working for a large Alabama media company. I'm currently looking to speak with drug reps, marketers or distributors that have been involved in the process of selling opioid type drugs in Alabama. Your anonymity is guaranteed. My request is hot-on-the-heels of the...

Seems things are not going right on all fronts post the Virginia incident during the weekend. Post the incident, Merck CEO is taking a stand against intolerance and extremism and announced today that he is stepping down from Trump's Manufacturing Council. But do you feel any repercussions on...

Apparently, Soliris drug sales are increasing. https://alphastreet.com/bite/4dac307 But how long can this company run on this? Given, the company has also announced that it is reducing the R&D expense for the year.

Valeant has entered into an agreement to sell its Obagi Medical Products business for $190MM in cash to Haitong International Zhonghua Finance Acquisition Fund I, L.P. $VRX intends to use the proceeds from the sale to permanently repay term loan debt under its Senior Secured Credit Facility...

Valeant could be back to growing again. The company pays down $811million of senior secured term loans using the net proceeds of the sale of Dendreon Pharmaceuticals LLC.